Is Deciphera Pharmaceuticals, Inc. (DCPH) a Buy, Sell, or Hold?
NASDAQ : DCPH
Deciphera Pharmaceuticals, Inc. — Insider Trades
$25.59 USD
$0.02 (0.08%)
- Volume
- 1.57M
- Average Volume
- 1.92M
- Market Capitalization
- $2.21B
- P/E Ratio
- -11.17
- Dividend Yield
- 0.00%
- Price Target
- $25.60
- Year High
- $25.61
- Year Low
- $9.90
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.80
Insider Activity Summary (Last 12 Months)
Insiders Buying
31
Insiders Selling
22
Amount of Insider Selling
$1.07M
DCPH Insider Buying/Selling by Quarter
DCPH Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Brightstar Associates LLC | 10 percent owner | 2024-04-22 | X-InTheMoney | 0.01 | 2024-04-24 |
| Brightstar Associates LLC | 10 percent owner | 2024-04-22 | X-InTheMoney | 0.01 | 2024-04-24 |
| Sherman Matthew L | officer: EVP & Chief Medical Officer | 2024-02-15 | A-Award | 0 | 2024-02-20 |
| Sherman Matthew L | officer: EVP & Chief Medical Officer | 2024-02-16 | S-Sale | 15.6177 | 2024-02-20 |
| Sherman Matthew L | officer: EVP & Chief Medical Officer | 2024-02-15 | A-Award | 15.92 | 2024-02-20 |
| Kelly Thomas Patrick | officer: Chief Financial Officer | 2024-02-15 | A-Award | 0 | 2024-02-20 |
| Kelly Thomas Patrick | officer: Chief Financial Officer | 2024-02-16 | S-Sale | 15.6177 | 2024-02-20 |
| Kelly Thomas Patrick | officer: Chief Financial Officer | 2024-02-15 | A-Award | 15.92 | 2024-02-20 |
| Pitman Jama | officer: SVP, Chief Development Officer | 2024-02-15 | A-Award | 0 | 2024-02-20 |
| Pitman Jama | officer: SVP, Chief Development Officer | 2024-02-16 | S-Sale | 15.6176 | 2024-02-20 |
| Pitman Jama | officer: SVP, Chief Development Officer | 2024-02-15 | A-Award | 0 | 2024-02-20 |
| Pitman Jama | officer: SVP, Chief Development Officer | 2024-02-15 | A-Award | 15.92 | 2024-02-20 |
| Hoerter Steven L. | director, officer: President and CEO | 2024-02-15 | A-Award | 15.92 | 2024-02-20 |
| Dhanak Dashyant | officer: EVP & Chief Scientific Officer | 2024-02-15 | A-Award | 0 | 2024-02-20 |
| Dhanak Dashyant | officer: EVP & Chief Scientific Officer | 2024-02-15 | A-Award | 15.92 | 2024-02-20 |
| Martin Daniel C. | officer: Chief Commercial Officer | 2024-02-15 | A-Award | 0 | 2024-02-20 |
| Martin Daniel C. | officer: Chief Commercial Officer | 2024-02-16 | S-Sale | 15.6176 | 2024-02-20 |
| Martin Daniel C. | officer: Chief Commercial Officer | 2024-02-15 | A-Award | 15.92 | 2024-02-20 |
| Brightstar Associates LLC | 10 percent owner | 2024-02-07 | X-InTheMoney | 0.01 | 2024-02-09 |
| Brightstar Associates LLC | 10 percent owner | 2024-02-07 | X-InTheMoney | 0.01 | 2024-02-09 |
| Sherman Matthew L | officer: EVP & Chief Medical Officer | 2024-01-16 | S-Sale | 14.4697 | 2024-01-18 |
| Walsh Dennis Leo | director | 2024-01-16 | A-Award | 14.46 | 2024-01-18 |
| Pitman Jama | officer: SVP, Chief Development Officer | 2024-01-16 | S-Sale | 14.4698 | 2024-01-18 |
| Friedman Franklin Stuart | director | 2024-01-16 | A-Award | 14.46 | 2024-01-18 |
| Kelly Thomas Patrick | officer: Chief Financial Officer | 2024-01-16 | S-Sale | 14.4698 | 2024-01-18 |
| Allen Patricia L | director | 2024-01-16 | A-Award | 14.46 | 2024-01-18 |
| Martin Daniel C. | officer: Chief Commercial Officer | 2024-01-16 | S-Sale | 14.4697 | 2024-01-18 |
| Squarer Ron | director | 2024-01-16 | A-Award | 14.46 | 2024-01-18 |
| Hoerter Steven L. | director, officer: President and CEO | 2023-12-12 | A-Award | 0 | 2023-12-14 |
| Hoerter Steven L. | director, officer: President and CEO | 2023-12-13 | S-Sale | 15.3671 | 2023-12-14 |
| Kelly Thomas Patrick | officer: Chief Financial Officer | 2023-12-12 | A-Award | 0 | 2023-12-14 |
| Kelly Thomas Patrick | officer: Chief Financial Officer | 2023-12-13 | S-Sale | 15.3671 | 2023-12-14 |
| Pitman Jama | officer: See Remarks | 2023-12-12 | A-Award | 0 | 2023-12-14 |
| Pitman Jama | officer: See Remarks | 2023-12-13 | S-Sale | 15.3671 | 2023-12-14 |
| Martin Daniel C. | officer: Chief Commercial Officer | 2023-12-12 | A-Award | 0 | 2023-12-14 |
| Martin Daniel C. | officer: Chief Commercial Officer | 2023-12-13 | S-Sale | 15.3671 | 2023-12-14 |
| Sherman Matthew L | officer: EVP & Chief Medical Officer | 2023-12-12 | A-Award | 0 | 2023-12-14 |
| Sherman Matthew L | officer: EVP & Chief Medical Officer | 2023-12-13 | S-Sale | 15.3671 | 2023-12-14 |
| Martin Daniel C. | officer: Chief Commercial Officer | 2023-11-30 | S-Sale | 12.5698 | 2023-12-01 |
| Sherman Matthew L | officer: EVP & Chief Medical Officer | 2023-10-28 | A-Award | 0 | 2023-10-31 |
| Sherman Matthew L | officer: EVP & Chief Medical Officer | 2023-10-30 | S-Sale | 12.0176 | 2023-10-31 |
| Pitman Jama | officer: See Remarks | 2023-10-28 | A-Award | 0 | 2023-10-31 |
| Pitman Jama | officer: See Remarks | 2023-10-30 | S-Sale | 12.0176 | 2023-10-31 |
| Martin Daniel C. | officer: Chief Commercial Officer | 2023-10-28 | A-Award | 0 | 2023-10-31 |
| Martin Daniel C. | officer: Chief Commercial Officer | 2023-10-30 | S-Sale | 12.0176 | 2023-10-31 |
| Kelly Thomas Patrick | officer: Chief Financial Officer | 2023-10-28 | A-Award | 0 | 2023-10-31 |
| Kelly Thomas Patrick | officer: Chief Financial Officer | 2023-10-30 | S-Sale | 12.0176 | 2023-10-31 |
| Hoerter Steven L. | director, officer: President and CEO | 2023-10-28 | A-Award | 0 | 2023-10-31 |
| Hoerter Steven L. | director, officer: President and CEO | 2023-10-30 | S-Sale | 12.0176 | 2023-10-31 |
| Sherman Matthew L | officer: EVP & Chief Medical Officer | 2023-10-02 | S-Sale | 12.68 | 2023-10-04 |
| Dhanak Dashyant | officer: EVP & Chief Scientific Officer | 2023-09-15 | A-Award | 0 | 2023-09-19 |
| Dhanak Dashyant | officer: EVP & Chief Scientific Officer | 2023-09-15 | A-Award | 13.42 | 2023-09-19 |
| Dhanak Dashyant | officer: EVP & Chief Scientific Officer | 2023-09-15 | A-Award | 0 | 2023-09-19 |
| Dhanak Dashyant | officer | 2023-09-05 | 0 | 2023-09-05 | |
| Martin John Richard | director | 2023-06-21 | A-Award | 14.91 | 2023-06-23 |
| Benz Edward J. JR | director | 2023-06-21 | A-Award | 14.91 | 2023-06-23 |
| Bristol James Arthur | director | 2023-06-21 | A-Award | 14.91 | 2023-06-23 |
| Friedman Franklin Stuart | director | 2023-06-21 | A-Award | 14.91 | 2023-06-23 |
| Walsh Dennis Leo | director | 2023-06-21 | A-Award | 14.91 | 2023-06-23 |
| Kelley Susan L. | director | 2023-06-21 | A-Award | 14.91 | 2023-06-23 |
| Squarer Ron | director | 2023-06-21 | A-Award | 14.91 | 2023-06-23 |
| Allen Patricia L | director | 2023-06-21 | A-Award | 14.91 | 2023-06-23 |
| Pitman Jama | officer: See Remarks | 2023-06-16 | S-Sale | 14.4018 | 2023-06-21 |
| Sherman Matthew L | officer: EVP & Chief Medical Officer | 2023-06-16 | S-Sale | 14.4018 | 2023-06-21 |
| Kelly Thomas Patrick | officer: Chief Financial Officer | 2023-06-16 | S-Sale | 14.4018 | 2023-06-21 |
| Martin Daniel C. | officer: Chief Commercial Officer | 2023-06-16 | S-Sale | 14.4018 | 2023-06-21 |
| Flynn Daniel Lee | officer: Chief Scientific Officer | 2023-06-16 | S-Sale | 14.4018 | 2023-06-21 |
| Friedman Franklin Stuart | director | 2023-06-08 | P-Purchase | 13.8828 | 2023-06-12 |
| Walsh Dennis Leo | director | 2023-05-10 | P-Purchase | 13.856 | 2023-05-12 |
| Hoerter Steven L. | director, officer: President and CEO | 2023-03-21 | S-Sale | 15.5709 | 2023-03-23 |
| Brightstar Associates LLC | 10 percent owner | 2023-02-28 | X-InTheMoney | 0.01 | 2023-03-01 |
| Brightstar Associates LLC | 10 percent owner | 2023-02-28 | X-InTheMoney | 0.01 | 2023-03-01 |
| Pitman Jama | officer: See Remarks | 2023-02-15 | A-Award | 0 | 2023-02-17 |
| Pitman Jama | officer: See Remarks | 2023-02-16 | S-Sale | 15.099 | 2023-02-17 |
| Pitman Jama | officer: See Remarks | 2023-02-15 | A-Award | 15.48 | 2023-02-17 |
| Martin Daniel C. | officer: Chief Commercial Officer | 2023-02-15 | A-Award | 0 | 2023-02-17 |
| Martin Daniel C. | officer: Chief Commercial Officer | 2023-02-16 | S-Sale | 15.099 | 2023-02-17 |
| Martin Daniel C. | officer: Chief Commercial Officer | 2023-02-15 | A-Award | 15.48 | 2023-02-17 |
| Kelly Thomas Patrick | officer: Chief Financial Officer | 2023-02-15 | A-Award | 15.48 | 2023-02-17 |
| Kelly Thomas Patrick | officer: Chief Financial Officer | 2023-02-15 | A-Award | 0 | 2023-02-17 |
| Kelly Thomas Patrick | officer: Chief Financial Officer | 2023-02-16 | S-Sale | 15.099 | 2023-02-17 |
| Sherman Matthew L | officer: EVP & Chief Medical Officer | 2023-02-15 | A-Award | 0 | 2023-02-17 |
| Sherman Matthew L | officer: EVP & Chief Medical Officer | 2023-02-16 | S-Sale | 15.099 | 2023-02-17 |
| Sherman Matthew L | officer: EVP & Chief Medical Officer | 2023-02-15 | A-Award | 15.48 | 2023-02-17 |
| Flynn Daniel Lee | officer: Chief Scientific Officer | 2023-02-15 | A-Award | 15.48 | 2023-02-17 |
| Flynn Daniel Lee | officer: Chief Scientific Officer | 2023-02-15 | A-Award | 0 | 2023-02-17 |
| Flynn Daniel Lee | officer: Chief Scientific Officer | 2023-02-16 | S-Sale | 15.099 | 2023-02-17 |
| Hoerter Steven L. | director, officer: President and CEO | 2023-02-15 | A-Award | 15.48 | 2023-02-16 |
| Hoerter Steven L. | director, officer: President and CEO | 2023-02-14 | S-Sale | 16 | 2023-02-16 |
| Brightstar Associates LLC | director | 2023-01-24 | P-Purchase | 18 | 2023-01-24 |
| Friedman Franklin Stuart | director | 2023-01-17 | A-Award | 15.2952 | 2023-01-19 |
| Flynn Daniel Lee | officer: Chief Scientific Officer | 2023-01-17 | S-Sale | 21.2413 | 2023-01-19 |
| Pitman Jama | officer: See Remarks | 2023-01-17 | S-Sale | 21.2413 | 2023-01-19 |
| Sherman Matthew L | officer: EVP & Chief Medical Officer | 2023-01-17 | S-Sale | 21.2413 | 2023-01-19 |
| Allen Patricia L | director | 2023-01-17 | A-Award | 15.2952 | 2023-01-19 |
| Martin Daniel C. | officer: Chief Commercial Officer | 2023-01-17 | S-Sale | 21.2413 | 2023-01-19 |
| Kelly Thomas Patrick | officer: Chief Financial Officer | 2023-01-17 | S-Sale | 21.2413 | 2023-01-19 |
| Walsh Dennis Leo | director | 2023-01-17 | A-Award | 15.2952 | 2023-01-19 |
| Squarer Ron | director | 2023-01-17 | A-Award | 15.2952 | 2023-01-19 |
| Kelley Susan L. | director | 2023-01-17 | A-Award | 15.2952 | 2023-01-19 |